Table 2.
Univariate and multivariate analyses of patients with the disease progression of melanoma.
| Variable | Univariate analysis | p-value | Multivariate analysis | p-value |
|---|---|---|---|---|
| Age (≥60 vs. <60) |
1.432 (0.995–2.061) |
0.053 | ||
| Gender (Male vs. Female) |
0.981 (0.679–1.419) |
0.981 | ||
| BMI (≥24 vs. <24) |
0.637 (0.371–1.096) |
0.103 | ||
| TNM stage (III–IV vs. I–II) |
2.699 (1.887–3.860) |
<0.001 | 2.357 (1.429–3.890) |
0.001 |
| lncPOU3F3 (High vs. Low) |
1.541 (1.079–2.202) |
0.017 | 1.591 (0.955–2.649) |
0.074 |
BMI, Body mass index.